# EDGAR Filing Document

**Accession Number:** 0001956982
**File Stem:** 0001443984-23-000017
**Filing Date:** 2023-1
**Character Count:** 9901
**Document Hash:** 81c178fbe5a7e55e5fb2ecc0a1a14723
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001443984-23-000017.hdr.sgml**: 20230127

**ACCESSION NUMBER**: 0001443984-23-000017

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230126

**FILED AS OF DATE**: 20230127

**DATE AS OF CHANGE**: 20230127

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Todorov Dimiter
- **CENTRAL INDEX KEY:** 0001956982

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-11593
- **FILM NUMBER:** 23561036

**MAIL ADDRESS:**
- **STREET 1:** 14111 SCOTTSLAWN RD
- **CITY:** MARYSVILLE
- **STATE:** OH
- **ZIP:** 43041
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SCOTTS MIRACLE-GRO CO
- **CENTRAL INDEX KEY:** 0000825542
- **STANDARD INDUSTRIAL CLASSIFICATION:** AGRICULTURE CHEMICALS [2870]
- **IRS NUMBER:** 311414921
- **STATE OF INCORPORATION:** OH
- **FISCAL YEAR END:** 0930

**BUSINESS ADDRESS:**
- **STREET 1:** 14111 SCOTTSLAWN ROAD
- **CITY:** MARYSVILLE
- **STATE:** OH
- **ZIP:** 43041
- **BUSINESS PHONE:** 9376440011

**MAIL ADDRESS:**
- **STREET 1:** 14111 SCOTTSLAWN ROAD
- **STREET 2:** N/A
- **CITY:** MARYSVILLE
- **STATE:** OH
- **ZIP:** 43041

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SCOTTS COMPANY
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CDS HOLDING CORP
- **DATE OF NAME CHANGE:** 19900104

## Ex-24

```

POWER OF ATTORNEY

    The undersigned officer and/or director of The Scotts Miracle-Gro Company
(the "Company"), hereby constitutes and appoints each of Bernard
K. Asirifi and Kathy L. Uttley, signing singly, the undersigned's true and
lawful attorney-in-fact and agent to:

1) execute for, in the name of and on behalf of the undersigned Forms 3, 4 and
5 with respect to the securities of the Company beneficially owned by the
undersigned in accordance with Section 16(a) of the Securities Exchange
Act of 1934, as amended (the "1934 Act") and the rules and regulations
thereunder and Form 144 with respect to the securities of the Company
beneficially owned by the undersigned in accordance with Rule 144 under the
Securities Act of 1933, as amended (the "Securities Act");

2) do and perform any and all acts for, in the name of and on behalf of the
undersigned which may be necessary or desirable to complete and execute any
such Form 3, 4 or 5 or such Form 144, complete and execute any amendment or
amendments thereto, and timely file any such form (and any such amendment or
amendments) with the United States Securities and Exchange Commission and any
stock exchange or similar authority; and

3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit
to, in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf
of the undersigned pursuant to this Power of Attorney shall be in such form
and shall contain such terms and conditions as such attorney-in-fact may
approve in such attorney-in-fact's discretion.

    The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform each and every act and thing
whatsoever requisite, necessary or proper to be done in the exercise of
any of the rights and powers herein granted, as fully to all intents and
purposes as the undersigned might or could do if personally present, with
full power of substitution and resubstitution, hereby ratifying and confirming
all that such attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of this Power
of Attorney and the rights and powers herein granted.  The undersigned
acknowledges that the above-named attorneys-in-fact, in serving in such
capacity at the request of the undersigned, are not assuming, nor is the
Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the 1934 Act and/or Rule 144 under the Securities Act.

    This Power of Attorney shall remain in full force and effect until
the undersigned is no longer required to file Forms 3, 4 and 5 or Form 144
with respect to the undersigned's holdings of and transactions in securities
issued by the Company, unless earlier revoked by the undersigned in a signed
writing delivered to the above-named attorneys-in-fact.  I hereby revoke all
previous Powers of Attorney that have been granted by me in connection with
my reporting obligations under the 1934 Act or the Securities Act with respect
to my holdings of and transactions in securities issued by the Company.

    IN WITNESS WHEREOF, the undersigned has caused this Power
of Attorney to be executed as of this 2nd day of December, 2022.

                    /s/ DIMITER TODOROV
                    Signature

                        Dimiter Todorov
                    Print Name

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Todorov Dimiter<br><sub>(Last) (First) (Middle)</sub><br>C/O THE SCOTTS MIRACLE-GRO COMPANY<br>14111 SCOTTSLAWN ROAD<br><sub>(Street)</sub><br>MARYSVILLE, OH 43041<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-01-26 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_EVP, GC & CORPORATE SECRETARY_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>SCOTTS MIRACLE-GRO CO [ SMG ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Shares | 2023-01-26<sup>(1)</sup> |  | A |  | 986 | A | $0 | 8746 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) On February 3, 2020, the Issuer made a grant to the Reporting Person of 808 performance units (the "2020 grant"). Under the award agreement, the 2020 grant included an enhanced issuance provision under which the Reporting Person would receive a range of 50% to 250% of the original grant depending on certain pre-determined performance criteria over the entirety of the plan period. On January 26, 2023, the Compensation Committee of the Issuer's Board of Directors determined that the performance measures related to the 2020 grant were satisfied to the extent required to permit for the issuance of shares equal to 122% of the original grant.

**Signature:** Kathy L. Uttley as attorney-in-fact for Dimiter Todorov  
**Date:** 2023-01-27

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**